Top CMOs in APAC-2021
Pharma Tech Outlook
Yuhan: One-Stop Custom Synthesis Services
line

Top 10 CMOs in APAC - 2021

line

With the growing demand for generic medicines and biologics,  pharmaceutical companies have identified the potential  profitability in contracting with a contract manufacturing  organization (CMO) for both clinical and commercial stage  manufacturing. By partnering with the right CM, a medical  device manufacturer can save plenty of time and overhead costs. The increased  demand for capable and dependable CMOs has seen the global CMO market growing  at an unprecedented rate. Another reason for this growth is the unexpected hit of  the COVID-19 pandemic. To look for a cure, pharma giants are leaving no stones  unturned to find a cure to this highly contagious virus. Other factors driving the  growth of CMOs in the pharmaceutical industry is the growing need for state-ofthe-  art processes and production technologies, which have proven highly effective in  meeting regulatory requirements.  CMOs are consolidating as a means of improving profitability in the competitive  market. They are looking at new technologies to boost economies of scale, improve  manufacturing productivity, and overall efficiency. To expand their capabilities and  global market reach, these companies are entering into new alliances through mergers  and acquisitions. Further, the relationship of pharmaceutical manufacturers with CMO  and contract development and manufacturing organizations (CDMOs) is increasingly  evolving from one-dimensional product outsourcing into a broad partnership model  involving several aspects of development, testing, production and research.Although  smaller firms have equal dependence as large drug companies on their CMO/CDMO  partners, their priority is focused on a different set of solution offerings.While pharma  companies refocus their core strengths and assets, CDMOs are playing a crucial role  in providing added facilities to mitigate the risk of supply shortages by supplying  multisite strategies and backup capacities.  With CMOs entering the APAC market with their competitive solutions,  companies need help to identify the right CMO partner. To help companies choose  the right CMO solution partners best suited for them, Pharma Tech Outlook has  compiled a list of top 10 CMOs in APAC. These companies are transforming the  pharma landscape with various disruptive technologies and best in class solutions.  We bring you PharmaTech Outlook’s “Top 10 CMOs in APAC - 2021.”        

    Top CMOs in APAC

    Bora Pharmaceuticals is a premier international CGMP CDMO specializing in complex oral solid dosage (tablet & capsules), liquids (solutions, suspensions, & nasal sprays) and semi-solids (creams & gels) pharmaceutical Rx and OTC products for late-phase Clinical through Commercial manufacturing and packaging. Bora owns and operates three state-of-the-art CGMP manufacturing facilities (Taiwan and Canada) built to the highest international standards for manufacturing, packaging, R&D, and analytical testing. The company can handle high potency compounds, solvents, flammables, and IR/SR/ER release profile products. What make it unique in semi-solids and liquids is its ability to manufacture from clinical to commercial scales with high throughput and the ability to handle solvents ... read full profile
    Accompanied by its analytical expertise, Formosa Laboratories streamlines the timeline of the formulation development to manufacturing for drug submission by achieving parallel active pharmaceutical ingredient and finished product development. The company, with its sister company, EirGenix Biotech, offers one-stop CDMO service in the development and manufacture of ADCs, including antibody development and production, synthesis of linker and payload, bio-conjugation, downstream purification, and the final fill-finish. The process control that is implemented in Formosa’s state-of-the-art injectable facility is advantageous in many aspects. One commercial high-speed line aseptically fills liquid for non-cytotoxic products can reach 18,000 vials per hour with a 100 percent weight check for IPC ... read full profile
    OLIC acts as a “One Stop Service” to the customers, providing flexibility to adhere to the customers’ requirements for the market’s unique and new dosage forms. Built on the values of gratitude, empathy, and trustworthiness, OLIC (Thailand) Ltd. is a 37-year-old contract manufacturing organization (CMO) delivering greater value to the healthcare and pharmaceutical companies in the Asia Pacific (APAC) region. OLIC has earned a reputation for reliability and impeccable quality standards over the years, thanks to its commitment and focus to producing products that are not only difficult to manufacture technically but also mandate stringent regulatory requirements ... read full profile
    Founded in 1997, ScinoPharm Taiwan is a global manufacturer of Active Pharmaceutical Ingredients (APIs), providing a wide array of APIs and the development and manufacturing services of intermediates. The company offers a wide range of injectable formulation development services for liquid formulations in vials, cartridges, and pre-filled syringes or lyophilized formulations. ScinoPharm’s formulation development laboratory can handle high potency drugs and has the R&D capabilities to facilitate drug registration. The firm’s formulation development team comprises experts with professional knowledge in formulation development, analytical method development, lyophilization cycle optimization, and process scale-up for NDA and ANDA dossier. ScinoPharm is also focusing on the injectables CDMO business¸ especially combination injectable products ... read full profile
    Yuhan is a leading pharmaceutical company in Korea that operates one-stop CDMO business as well as pharmaceuticals, consumer healthcare, and animal healthcare. Founded to solve widespread public health problems, the company still believes in making the best medicines and contributing to public health. Aligning with this goal, one of its business divisions, a fully integrated CDMO, provides customized services for small-molecule intermediates and APIs. With comprehensive contract manufacturing services offering the promise of quality, consistency, and reliability, Yuhan stands rooted in its integrity and social responsibilities legacy ... read full profile
    Genero
    Genero is a reputable company, part of the Arya Noble Group Company, that was established in 2000. In the last 17 years, Genero has evolved from a company that specializes in creating dermatology products for ERHA group into an innovative and competitive company that provides integrated services for dermatology. The company is currently a strategic partner in supply chain management for several leading national and multinational companies
    Hikal
    Established in 1988, Hikal is a reliable partner to companies in the Pharmaceutical, Animal Health, Biotech, Crop Protection and Specialty Chemical industries. The company manufacture and supply quality Active Ingredients, Intermediates, Biocides to the global life sciences industry. Hikal has five manufacturing facilities in India at Maharashtra (Taloja and Mahad), Gujarat (Panoli) and Bengaluru (Jigani) and a world-class Research & Technology centre at Pune
    Hope Chem
    Hope Chem is dedicated to manufacturing, marketing and CMO service of Active Pharmaceutical Ingredients (APIs), Intermediates and Specialty Chemicals since year 2010. Currently the company have exclusive partnerships with multiple, state of the art and GMP compliant manufacturers in China and abroad to service its esteemed partners for competitive, long-term & stable supplies
    Linkchem
    LinkChem is a leading China headquartered CMO | CRO provider within the pharmaceutical industry. The company's core focus includes custom synthesis, process development, and manufacturing of key intermediates, API, amino acid and peptides. LinkChem supports the virtually integrated pharma company with unparalleled expertise throughout the entire product lifecycle
    Sypharma
    Sypharma offers contract manufacturing services to the pharmaceutical, veterinary and consumer goods industries, with a specialist program for clinical trial material and drug development. As Sypharma expands its chemical and microbiological laboratories the company can increasingly offer extra laboratory services. Sypharma provides its clients with a broad range of formulations, batch sizes, and packaging formats to accommodate their requirements